Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase

Endocrinology

Volumn 142, Issue 1, 2001, Pages 276-289

  Authier, François ^a,e   Danielsen, Gillian M ^b   Kouach, Mostafa ^c   Briand, Gilbert ^c   Chauvet, Genevieve ^d  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b NOVO NORDISK A S   (Denmark)

^c UNIV LILLE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULINASE; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL FRACTIONATION; CONTROLLED STUDY; ENDOSOME; INSULIN BINDING; INSULIN DEGRADATION; INTERNALIZATION; LIVER CELL; MALE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN TARGETING; RAT;

EID: 0035114992     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7916     Document Type: Article

References (44)

1. Compartmentalized signal transduction by receptor tyrosine kinases
2. Hepatic endosomes are a major physiological locus of insulin and glucagon degradation in vivo
3. Endosomal proteolysis of internalized proteins
4. Physiological functions of endosomal proteolysis
5. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme
6. The dephosphorylation of insulin and epidermal growth factor receptors
7. B27] insulin in rat liver in vivo
8. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake
9. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects
10. Role of the COOH-terminal B-chain domain in insulin-receptor interaction. Identification of perturbations involving the insulin mainchain
11. Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells
12. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin
13. B24]-insulin
14. Receptor-binding region of insulin
15. A superactive insulin
16. Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: Relationship to the kinetic properties of the hormone-receptor interaction
17. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency
18. Fate of injected glucagon taken up by rat liver in vivo
19. Protein measurement with the Folin phenol reagent
20. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease
21. Rat procathepsin B
22. Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D
23. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin
24. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase
25. Immunolocalization of thimet oligopeptidase in chicken embryonic fibroblasts
26. Degradation of glucagon in isolated liver endosomes
27. Ligand-mediated internalization of glucagon receptors in intact rat liver
28. Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B
29. Endosome-lysosome transfer of insulin and glucagon in a liver cell-free system
30. In vitro endosome-lysosome transfer of dephosphorylated EGF receptor and Shc in rat liver
31. Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification
32. Characterization of insulin degradation products generated in liver endosomes: In vivo and in vitro studies
33. The characterization of endosomal insulin degradation intermediates and their sequence of production
34. The degradation of monoiodotyrosyl insulin isomers bY insulin protease
35. Purification and characterization of insulin-degrading enzyme from human erythrocytes
36. Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: The endosomal apparatus
37. Selective degradation of insulin within rat liver endosomes
38. Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin
39. 14C]sucrose-insulin in perfused rat livers
40. Degradation of epidermal growth factor receptor in rat liver
41. Epidermal growth factor and transforming growth factor-alpha: Differential intracellular routing and processing of ligand-receptor complexes
42. Reconstitution of an endosome-lysosome interaction in a cell-free system
43. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma
44. Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor